Trials / Conditions / CTIT-Chemotherapy Induced Thrombocytopenia
CTIT-Chemotherapy Induced Thrombocytopenia
5 registered clinical trials studyying CTIT-Chemotherapy Induced Thrombocytopenia — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, NCT07243418 | Fujian Cancer Hospital | Phase 2 |
| Not Yet Recruiting | A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in th NCT07252375 | Fujian Cancer Hospital | Phase 2 |
| Not Yet Recruiting | A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 i NCT07185893 | Jun wang | N/A |
| Enrolling By Invitation | TPO Combined With TPORA for Solid Tumors Effectiveness of cTit Above Degree II NCT06769685 | Jinhua Central Hospital | — |
| Not Yet Recruiting | A Multicenter Randomized Controlled Study on the Treatment of Refractory CTIT With Romiplostim N01 Compared to NCT06440824 | Shandong University | Phase 3 |